Full Title
A Phase 2, multicenter, open-label study of lifileucel (tumor-infiltrating lymphocytes [TIL]) in participants with previously treated advanced soft tissue sarcomaPurpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Lauren Banks’s office at 646-608-2091.
Protocol
26-361
Phase
Phase II (phase 2)
Investigator
Co-Investigators
Diseases
Locations
ClinicalTrials.gov ID
NCT07741877
ClinicalTrials.gov